Medicare Enrolled
Dr. Omaima Degani, M.D.
Nephrology · Gurnee, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Degani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Degani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Degani
Dr. Omaima Degani is a nephrology specialist in Gurnee, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Degani performed 3,194 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Degani received a total of $135,735 from 40 pharmaceutical and/or device companies across 464 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Degani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 8% volume in IL
$135,735 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,194
Medicare services
Top 8% in IL for nephrology
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
726 | $98 | $213 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
670 | $6 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
536 | $75 | $270 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
358 | $46 | $128 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
227 | $141 | $419 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
178 | $281 | $648 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
162 | $59 | $157 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
106 | $65 | $149 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
102 | $239 | $540 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $12 | $30 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
37 | $81 | $116 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
27 | $240 | $540 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $65 | $187 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $105 | $605 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$135,735
Total received (2018-2024)
Avg $19,391/year across 7 years
Top 2% in IL for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
464
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$63,673
2023
$36,367
2022
$22,342
2021
$6,475
2020
$183
2019
$1,623
2018
$5,073
Payments by company (2024)
Mallinckrodt Hospital Products Inc.
$28,733
Travere Therapeutics, Inc.
$20,481
AstraZeneca Pharmaceuticals LP
$13,147
Recor Medical Inc
$238
Amgen Inc.
$224
Lilly USA, LLC
$173
Fresenius USA Marketing, Inc.
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
Bayer Healthcare Pharmaceuticals Inc.
$83
Ardelyx, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$78
Novartis Pharmaceuticals Corporation
$60
ANI Pharmaceuticals, Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$25
GlaxoSmithKline, LLC.
$24
Vifor Pharma, Inc.
$24
Alexion Pharmaceuticals, Inc.
$18
Top 3 companies account for 97.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$49,862
Mallinckrodt Hospital Products Inc.
$29,112
Travere Therapeutics, Inc.
$27,028
Aurinia Pharma U.S., Inc.
$13,335
Horizon Therapeutics plc
$5,872
OPKO Pharmaceuticals, LLC
$4,640
Amgen Inc.
$619
Mallinckrodt Enterprises LLC
$422
GENZYME CORPORATION
$400
NxStage Medical, Inc.
$347
Fresenius USA Marketing, Inc.
$319
Otsuka America Pharmaceutical, Inc.
$317
Relypsa, Inc.
$309
BARD PERIPHERAL VASCULAR, INC.
$267
Boston Scientific Corporation
$254
Novo Nordisk Inc
$241
Recor Medical Inc
$238
Mallinckrodt LLC
$210
Lilly USA, LLC
$193
Bayer Healthcare Pharmaceuticals Inc.
$181
ANI Pharmaceuticals, Inc.
$180
Bayer HealthCare Pharmaceuticals Inc.
$168
Vifor Pharma, Inc.
$129
Daiichi Sankyo Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
GlaxoSmithKline, LLC.
$105
Novartis Pharmaceuticals Corporation
$86
Ardelyx, Inc.
$82
Otsuka Pharmaceutical Development & Commercialization, Inc.
$80
Bard Peripheral Vascular, Inc.
$79
Exeltis, USA Inc.
$64
Ultragenyx Pharmaceutical Inc.
$54
Retrophin, Inc.
$48
Horizon Pharma plc
$37
Alexion Pharmaceuticals, Inc.
$33
Keryx Biopharmaceuticals, Inc.
$27
AKEBIA THERAPEUTICS INC
$23
AMAG Pharmaceuticals, Inc.
$21
Shire North American Group Inc
$11
Top 3 companies account for 78.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · Aranesp · Auryxia · BENLYSTA · BREZTRI · CABLIVI · CRYSVITA · Crysvita · Dialyzers · ENTRESTO · FARXIGA · FERAHEME · GATTEX · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · LUTONIX · NXSTAGE SYSTEM ONE · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · RYBELSUS · Rayaldee · Rayaldee (old) · Rybelsus · SAMSCA · SYSTEM ONE · TAVNEOS · TERLIVAZ · ULTOMIRIS · Uloric · Ultomiris · Velphoro · Veltassa · WATCHMAN · XPHOZAH 30 MG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
57
County median income
$108,917
Nearest hospital to ZIP centroid (approximate)
VISTA MEDICAL CENTER EAST
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Degani is a clinical cardiology specialist, with above-average Medicare volume (top 8% in IL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Degani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Degani performed 726 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Degani receive payments from pharmaceutical companies?
Yes. Dr. Degani received a total of $135,735 from 40 companies across 464 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Degani's costs compare to other nephrologists in Gurnee?
Dr. Degani's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Degani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Gurnee
Browse nephrologists in Gurnee ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in IL
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in IL
Which IL nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
Travere Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Travere Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology